Clinical Trial Update: NI-0401 in Active Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

The NI-0401 trial in active Crohn's disease has completed Phase 1 and Phase 2 studies. The sponsor is Light Chain Bioscience in collaboration with Novimmune SA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• NI-0401

Snippet

Sponsor: Light Chain Bioscience - Novimmune SA | Conditions: Moderate to Severe Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED